Omeros Corp. (OMER)
18.58
-0.66
(-3.45%)
USD |
NASDAQ |
Aug 28, 16:00
18.62
+0.04
(+0.19%)
After-Hours: 16:34
Omeros Net Income (Quarterly) : 6.637M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.637M |
| March 31, 2026 | 51.25M |
| December 31, 2025 | 79.89M |
| September 30, 2025 | -21.24M |
| June 30, 2025 | -25.89M |
| March 31, 2025 | -37.56M |
| December 31, 2024 | -36.54M |
| September 30, 2024 | -37.11M |
| June 30, 2024 | -65.12M |
| March 31, 2024 | -43.85M |
| December 31, 2023 | -39.29M |
| September 30, 2023 | -51.66M |
| June 30, 2023 | -44.29M |
| March 31, 2023 | -39.68M |
| December 31, 2022 | -46.05M |
| September 30, 2022 | -54.79M |
| June 30, 2022 | -41.70M |
| March 31, 2022 | -39.49M |
| December 31, 2021 | -47.31M |
| September 30, 2021 | -44.28M |
| June 30, 2021 | -50.19M |
| March 31, 2021 | -49.77M |
| December 31, 2020 | -39.98M |
| September 30, 2020 | -38.46M |
| June 30, 2020 | -33.29M |
| Date | Value |
|---|---|
| March 31, 2020 | -29.03M |
| December 31, 2019 | -29.22M |
| September 30, 2019 | -16.46M |
| June 30, 2019 | -14.45M |
| March 31, 2019 | -24.34M |
| December 31, 2018 | -23.53M |
| September 30, 2018 | -39.47M |
| June 30, 2018 | -33.70M |
| March 31, 2018 | -30.05M |
| December 31, 2017 | -16.55M |
| September 30, 2017 | -7.482M |
| June 30, 2017 | -14.36M |
| March 31, 2017 | -15.09M |
| December 31, 2016 | -19.63M |
| September 30, 2016 | -13.96M |
| June 30, 2016 | -12.61M |
| March 31, 2016 | -20.54M |
| December 31, 2015 | -19.83M |
| September 30, 2015 | -19.92M |
| June 30, 2015 | -16.68M |
| March 31, 2015 | -18.67M |
| December 31, 2014 | -20.71M |
| September 30, 2014 | -18.33M |
| June 30, 2014 | -17.99M |
| March 31, 2014 | -16.64M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.095B |
| Talphera, Inc. | -4.312M |
| Hyperion DeFi, Inc. | 30.95M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 28.53M |
| Total Expenses (Quarterly) | 21.89M |
| EPS Diluted (Quarterly) | 0.1476 |
| Enterprise Value | 1.553B |
| Gross Profit Margin (Quarterly) | 96.50% |
| Profit Margin (Quarterly) | 23.26% |
| Earnings Yield | 7.74% |
| Normalized Earnings Yield | 9.071 |